Literature DB >> 18590998

Neurodegenerative 'overlap' syndrome: Clinical and pathological features of Parkinson's disease, motor neuron disease, and Alzheimer's disease.

R J Uitti1, K Berry, O Yasuhara, A Eisen, H Feldman, P L McGeer, D B Calne.   

Abstract

Parkinson's disease (PD), Alzheimer's disease (AD), and motor neuron disease (MND) share epidemiological, clinical, and pathological features. Few studies have reported comprehensively on individuals who demonstrate a neurodegenerative 'overlap' syndrome, comprising idiopathic parkinsonism, dementia, and motor neuron dysfunction. We describe clinical, electrophysiological, and pathological features in six patients with neurodegenerative 'overlap' syndrome. All had cardinal features of PD (duration 6-26 years), and any mixture of dementia (slowly advancing), fasciculations, hyperreflexia, Babinski signs and mild atrophy and weakness of distal muscles (slowly progressive). EMG often demonstrated a lack of denervation in conjunction with abnormal MEPs (high thresholds). Patients had either 6FD-PET or pathological studies consistent with PD. Pathological studies also demonstrated moderate numbers of neurofibrillary tangles and plaque formation, typically with sparing of motor neurons in the spinal cord. We conclude that neurodegenerative 'overlap' syndrome may represent forme frustes of traditionally accepted diagnostic categories. Patients with parkinsonism, fasciculations, hyperreflexia and mild atrophy are unlikely to demonstrate active denervation on EMG; their prognosis is better than for classical MND. Neurodegenerative overlap syndrome (clinicopathological mixtures of PD, AD, and MND) may develop in some individuals as a reflection of common etiology, pathogenesis or susceptibility.

Entities:  

Year:  1995        PMID: 18590998     DOI: 10.1016/1353-8020(95)00004-p

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  11 in total

Review 1.  How to improve the diagnostic process.

Authors:  A Eisen
Journal:  J Neurol       Date:  1999-11       Impact factor: 4.849

Review 2.  Clinical aspects of familial forms of frontotemporal dementia associated with parkinsonism.

Authors:  Shinsuke Fujioka; Zbigniew K Wszolek
Journal:  J Mol Neurosci       Date:  2011-06-08       Impact factor: 3.444

3.  Genetic Counseling Dilemmas for a Patient with Sporadic Amyotrophic Lateral Sclerosis, Frontotemporal Degeneration & Parkinson's Disease.

Authors:  Vittorio Mantero; Claudia Tarlarini; Angelo Aliprandi; Giuseppe Lauria; Andrea Rigamonti; Lucia Abate; Paola Origone; Paola Mandich; Silvana Penco; Andrea Salmaggi
Journal:  J Genet Couns       Date:  2017-03-01       Impact factor: 2.537

4.  Clinical and neuroimaging characteristics in neurodegenerative overlap syndrome.

Authors:  Young-Min Lim; Hee Kyung Park; Jae Seung Kim; Chong Sik Lee; Sun Ju Chung; Jimin Kim; Kwang-Kuk Kim
Journal:  Neurol Sci       Date:  2012-06-28       Impact factor: 3.307

5.  ALS-FTD complex disorder due to C9ORF72 gene mutation: description of first Polish family.

Authors:  Joanna Siuda; Tatiana Lewicka; Malgorzata Bujak; Grzegorz Opala; Aleksandra Golenia; Agnieszka Slowik; Marka van Blitterswijk; Matt Baker; Nilufer Ertekin-Taner; Zbigniew K Wszolek; Rosa Rademakers
Journal:  Eur Neurol       Date:  2014-05-24       Impact factor: 1.710

6.  Parkinsonian Syndromes in Motor Neuron Disease: A Clinical Study.

Authors:  Jacopo Pasquini; Francesca Trogu; Claudia Morelli; Barbara Poletti; Floriano Girotti; Silvia Peverelli; Alberto Brusati; Antonia Ratti; Andrea Ciammola; Vincenzo Silani; Nicola Ticozzi
Journal:  Front Aging Neurosci       Date:  2022-06-27       Impact factor: 5.702

7.  ALS-Plus syndrome: non-pyramidal features in a large ALS cohort.

Authors:  Leo McCluskey; Shannon Vandriel; Lauren Elman; Vivianna M Van Deerlin; John Powers; Ashley Boller; Elisabeth McCarty Wood; John Woo; Corey T McMillan; Katya Rascovsky; Murray Grossman
Journal:  J Neurol Sci       Date:  2014-07-18       Impact factor: 3.181

8.  Association studies of MMP-9 in Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  Xianghua He; Lifang Zhang; Xiaoli Yao; Jing Hu; Lihua Yu; Hua Jia; Ran An; Zhuolin Liu; Yanming Xu
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

9.  C9ORF72 intermediate repeat copies are a significant risk factor for Parkinson disease.

Authors:  Karen Nuytemans; Güney Bademci; Martin M Kohli; Gary W Beecham; Liyong Wang; Juan I Young; Fatta Nahab; Eden R Martin; John R Gilbert; Michael Benatar; Jonathan L Haines; William K Scott; Stephan Züchner; Margaret A Pericak-Vance; Jeffery M Vance
Journal:  Ann Hum Genet       Date:  2013-07-12       Impact factor: 1.670

10.  Lack of c9orf72 repeat expansion in taiwanese patients with mixed neurodegenerative disorders.

Authors:  Chin-Hsien Lin; Ta-Fu Chen; Ming-Jang Chiu; Han-I Lin; Ruey-Meei Wu
Journal:  Front Neurol       Date:  2014-04-28       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.